Patient Guide: A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 91 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06298552
Status: ACTIVE_NOT_RECRUITING
Condition: Generalized Myasthenia Gravis
Phase: PHASE3

Where You Can Participate

This study is available at 91 locations across the country.

Top locations include:
  • • Scottsdale, Arizona
  • • Fresno, California
  • • Boca Raton, Florida
  • • And 88 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis - Join Clinical Trial NCTNCT06298552

How to Join This Clinical Trial - NCTNCT06298552

Learn how to participate in this PHASE3 trial studying an investigational therapy for Generalized Myasthenia Gravis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Generalized Myasthenia Gravis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Generalized Myasthenia Gravis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06298552 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 91 locations. Find a study site near you:

Clinical Research Site

Scottsdale, Arizona 85251 - United States

Status: Contact for availability

Clinical Research Site

Fresno, California 93701-2234 - United States

Status: Contact for availability

Clinical Research Site

Boca Raton, Florida 33428 - United States

Status: Contact for availability

Clinical Research Site

Boca Raton, Florida 33487 - United States

Status: Contact for availability

Clinical Research Site

Coral Springs, Florida 33067 - United States

Status: Contact for availability

Clinical Research Site

Maitland, Florida 32751 - United States

Status: Contact for availability

Clinical Research Site

Miami, Florida 33136 - United States

Status: Contact for availability

Clinical Research Site

Port Charlotte, Florida 33952 - United States

Status: Contact for availability

Clinical Research Site

Saint Petersburg, Florida 33705-1410 - United States

Status: Contact for availability

Clinical Research Site

Tampa, Florida 33612 - United States

Status: Contact for availability

And 81 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Generalized Myasthenia Gravis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships